Systemic manifestations of COVID-19

RK Mahajan, G Paul, R Mahajan… - Journal of …, 2020 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19), caused due to a novel coronavirus SARS-
CoV-2, has swept across the planet and has become a public health emergency of …

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

VP Chavda, N Raval, S Sheta, LK Vora… - Frontiers in …, 2023 - frontiersin.org
The newly emerged coronavirus (SARS-CoV-2) is virulent, contagious, and has rapidly
gained many mutations, which makes it highly infectious and swiftly transmissible around …

The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis

R Pranata, R Supriyadi, I Huang… - Clinical Medicine …, 2020 - journals.sagepub.com
Objective: The aim of the study was to evaluate the association between chronic kidney
disease (CKD) and new onset renal replacement therapy (RRT) with the outcome of …

2D MXenes for combatting COVID-19 Pandemic: A perspective on latest developments and innovations

S Panda, K Deshmukh, CM Hussain, SKK Pasha - FlatChem, 2022 - Elsevier
The COVID-19 pandemic has adversely affected the world, causing enormous loss of lives.
A greater impact on the economy was also observed worldwide. During the pandemic, the …

Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically‐ill COVID‐19 patients

V Premužić, J Babel, D Gardijan, I Lapić… - Therapeutic …, 2022 - Wiley Online Library
This study tried to investigate the impact of o**ris filter on both clinical and laboratory
parameters in critically‐ill COVID‐19 intensive care unit (ICU) patients receiving …

Предикторы клинической эффективности гемосорбции цитокинов при COVID-19

ВА Ратников, АН Щеглов… - Общая …, 2023 - reanimatology.com
Резюме Цель исследования. Выявить значимость предикторов клинической
эффективности гемосорбции цитокинов у пациентов с COVID-19. Материал и методы …

Extracorporeal blood purification in moderate and severe COVID-19 patients: a prospective cohort study

RA Rosalia, P Ugurov, D Neziri, S Despotovska… - Blood …, 2022 - karger.com
Abstract Introduction: Coronavirus disease 2019 (COVID-19) is characterized by
hyperinflammation and coagulopathy. Severe cases often develop respiratory distress …

[HTML][HTML] Epidemiological modeling of COVID-19 in Saudi Arabia: Spread projection, awareness, and impact of treatment

Y Alharbi, A Alqahtani, O Albalawi, M Bakouri - Applied Sciences, 2020 - mdpi.com
Featured Application In this work, the prediction of the spread of COVID-19 in Saudi Arabia
was analyzed and evaluated using different epidemiological models in order to choose the …

Efficacy of additional hemoperfusion in hospitalized patients with severe to critical COVID-19 disease

S Chiewroongroj, R Ratanarat, T Naorungroj… - Scientific Reports, 2024 - nature.com
The evidence supporting additional hemoperfusion (HP) with cytokine adsorbents for
improving clinical outcomes in severe to critical coronavirus disease 2019 (COVID-19) …

Cytokine adsorption in critically ill COVID-19 patients, a case-control study

R Abdullayev, F Gul, B Bilgili… - Journal of intensive …, 2022 - journals.sagepub.com
Aim: New coronavirus disease (COVID-19) has become an international emergency. As
many of the intensive care unit (ICU) patients with the disease also present multiple organ …